Ever Supreme Bio Technology Co., Ltd (TPEX:6712)
Taiwan
· Delayed Price · Currency is TWD 169.00
-1.50 (-0.88%)
At close: Dec 5, 2025
TPEX:6712 Ratios and Metrics
Market cap in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2016 |
| Market Capitalization | 14,804 | 14,158 | 14,338 | 15,025 | 13,013 | 9,856 | Upgrade
|
| Market Cap Growth | 1.11% | -1.25% | -4.57% | 15.46% | 32.03% | 8.98% | Upgrade
|
| Enterprise Value | 14,491 | 13,525 | 13,324 | 13,889 | 11,764 | 9,488 | Upgrade
|
| Last Close Price | 169.00 | 154.82 | 152.13 | 154.52 | 130.75 | 109.32 | Upgrade
|
| PE Ratio | 28.68 | 38.55 | 26.58 | 74.86 | 35.21 | - | Upgrade
|
| Forward PE | 29.04 | 42.17 | 41.07 | 44.55 | - | - | Upgrade
|
| PS Ratio | 14.72 | 15.16 | 18.91 | 23.94 | 29.65 | 139.61 | Upgrade
|
| PB Ratio | 10.65 | 7.89 | 7.78 | 8.38 | 6.86 | 12.62 | Upgrade
|
| P/TBV Ratio | 10.76 | 7.94 | 7.83 | 8.44 | 6.90 | 12.79 | Upgrade
|
| P/FCF Ratio | 25.19 | 32.51 | 34.47 | 47.55 | 97.33 | - | Upgrade
|
| P/OCF Ratio | 25.12 | 32.15 | 34.00 | 47.07 | 95.90 | - | Upgrade
|
| EV/Sales Ratio | 14.40 | 14.48 | 17.57 | 22.13 | 26.81 | 134.40 | Upgrade
|
| EV/EBITDA Ratio | 27.55 | 30.72 | 37.25 | 45.20 | 83.16 | - | Upgrade
|
| EV/EBIT Ratio | 28.93 | 32.11 | 39.45 | 48.94 | 101.24 | - | Upgrade
|
| EV/FCF Ratio | 24.66 | 31.06 | 32.04 | 43.95 | 87.99 | - | Upgrade
|
| Debt / Equity Ratio | 0.03 | 0.00 | 0.00 | 0.01 | 0.02 | 0.06 | Upgrade
|
| Debt / EBITDA Ratio | 0.09 | 0.01 | 0.02 | 0.06 | 0.23 | - | Upgrade
|
| Debt / FCF Ratio | 0.07 | 0.01 | 0.01 | 0.06 | 0.26 | - | Upgrade
|
| Asset Turnover | 0.55 | 0.44 | 0.38 | 0.31 | 0.31 | 0.08 | Upgrade
|
| Inventory Turnover | 3.15 | 3.67 | 3.48 | 2.94 | 4.19 | 3.52 | Upgrade
|
| Quick Ratio | 1.45 | 3.46 | 6.20 | 8.28 | 14.58 | 10.73 | Upgrade
|
| Current Ratio | 1.69 | 3.72 | 6.57 | 8.89 | 15.20 | 11.87 | Upgrade
|
| Return on Equity (ROE) | 35.06% | 20.19% | 29.68% | 10.88% | 27.60% | -13.13% | Upgrade
|
| Return on Assets (ROA) | 15.30% | 12.50% | 10.42% | 8.88% | 5.04% | -11.10% | Upgrade
|
| Return on Capital (ROIC) | 18.70% | 14.44% | 11.54% | 9.48% | 5.27% | -11.51% | Upgrade
|
| Return on Capital Employed (ROCE) | 31.20% | 23.30% | 18.30% | 15.70% | 6.00% | -19.20% | Upgrade
|
| Earnings Yield | 3.52% | 2.59% | 3.76% | 1.34% | 2.84% | -1.08% | Upgrade
|
| FCF Yield | 3.97% | 3.08% | 2.90% | 2.10% | 1.03% | -2.00% | Upgrade
|
| Dividend Yield | 2.75% | 3.01% | 3.26% | 0.97% | 2.61% | - | Upgrade
|
| Payout Ratio | 78.29% | 119.82% | 25.27% | 154.19% | - | - | Upgrade
|
| Buyback Yield / Dilution | 0.68% | 1.65% | 1.01% | -0.15% | -11.01% | -0.09% | Upgrade
|
| Total Shareholder Return | 3.41% | 4.66% | 4.27% | 0.83% | -8.40% | -0.09% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.